日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modified Irinotecan Plus Cisplatin and Dexamethasone (ICD) Combination Chemotherapy as Salvage Chemotherapy for Patients with Relapsed/Refractory Diffuse Large Cell Lymphoma

改良伊立替康联合顺铂和地塞米松(ICD)联合化疗方案作为复发/难治性弥漫性大B细胞淋巴瘤患者的挽救性化疗

Ghadiany, Mojtaba; Foratyazdi, Mohammad; Rahimi, Hossein; Rezvani, Hamid; Sadeghi, Lila; Fathali, Abbas Haji